Literature DB >> 7805862

Impaired copper binding by the H46R mutant of human Cu,Zn superoxide dismutase, involved in amyotrophic lateral sclerosis.

M T Carri1, A Battistoni, F Polizio, A Desideri, G Rotilio.   

Abstract

Several point mutations in the gene coding for human Cu,Zn superoxide dismutase have been reported as being responsible for familial amyotrophic lateral sclerosis (FALS). However, no direct demonstration has been provided for a correlation between total superoxide dismutase activity and severity of the FALS pathology. In order to get a better insight into the mechanism(s) underlying the FALS phenotype, we have investigated the activity and the copper binding properties of the single mutant H46R, which is associated with a Japanese form of FALS. We have shown that this mutant is structurally stable but lacks significant enzyme activity and has impaired capability of binding catalytic copper. The mutant protein can be fully reconstituted with copper in vitro but its ESR spectrum displays an axial shape quite different from that of the wild-type.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7805862     DOI: 10.1016/0014-5793(94)01295-4

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  12 in total

1.  Structural consequences of the familial amyotrophic lateral sclerosis SOD1 mutant His46Arg.

Authors:  Svetlana Antonyuk; Jennifer Stine Elam; Michael A Hough; Richard W Strange; Peter A Doucette; Jorge A Rodriguez; Lawrence J Hayward; Joan Selverstone Valentine; P John Hart; S Samar Hasnain
Journal:  Protein Sci       Date:  2005-05       Impact factor: 6.725

2.  Superoxide dismutase 1 modulates expression of transferrin receptor.

Authors:  Ruth Danzeisen; Tilmann Achsel; Ulrich Bederke; Mauro Cozzolino; Claudia Crosio; Alberto Ferri; Malte Frenzel; Edith Butler Gralla; Lea Huber; Albert Ludolph; Monica Nencini; Giuseppe Rotilio; Joan Selverstone Valentine; Maria Teresa Carrì
Journal:  J Biol Inorg Chem       Date:  2006-04-26       Impact factor: 3.358

3.  Chaperone-facilitated copper binding is a property common to several classes of familial amyotrophic lateral sclerosis-linked superoxide dismutase mutants.

Authors:  L B Corson; J J Strain; V C Culotta; D W Cleveland
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-26       Impact factor: 11.205

Review 4.  Oxidative damage to RNA: mechanisms, consequences, and diseases.

Authors:  Qiongman Kong; Chien-Liang Glenn Lin
Journal:  Cell Mol Life Sci       Date:  2010-02-11       Impact factor: 9.261

5.  Studies on the inactivation of superoxide dismutase activity by nitric oxide from rat peritoneal macrophages.

Authors:  B Joe; B R Lokesh
Journal:  Mol Cell Biochem       Date:  1997-03       Impact factor: 3.396

6.  Subunit asymmetry in the three-dimensional structure of a human CuZnSOD mutant found in familial amyotrophic lateral sclerosis.

Authors:  P J Hart; H Liu; M Pellegrini; A M Nersissian; E B Gralla; J S Valentine; D Eisenberg
Journal:  Protein Sci       Date:  1998-03       Impact factor: 6.725

7.  Glutamate potentiates the toxicity of mutant Cu/Zn-superoxide dismutase in motor neurons by postsynaptic calcium-dependent mechanisms.

Authors:  J Roy; S Minotti; L Dong; D A Figlewicz; H D Durham
Journal:  J Neurosci       Date:  1998-12-01       Impact factor: 6.167

8.  Rational De Novo Design of a Cu Metalloenzyme for Superoxide Dismutation.

Authors:  Emilie Mathieu; Audrey E Tolbert; Karl J Koebke; Cédric Tard; Olga Iranzo; James E Penner-Hahn; Clotilde Policar; Vincent Pecoraro
Journal:  Chemistry       Date:  2019-12-03       Impact factor: 5.236

Review 9.  Mitochondrial dysfunction in neurodegenerative diseases associated with copper imbalance.

Authors:  Luisa Rossi; Marco F Lombardo; Maria R Ciriolo; Giuseppe Rotilio
Journal:  Neurochem Res       Date:  2004-03       Impact factor: 3.996

Review 10.  The potential for transition metal-mediated neurodegeneration in amyotrophic lateral sclerosis.

Authors:  David B Lovejoy; Gilles J Guillemin
Journal:  Front Aging Neurosci       Date:  2014-07-23       Impact factor: 5.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.